AO ORFE

ORFE is a specialized Russian pharmaceutical distributor focused on the supply of high-tech and high-cost medicinal products for the treatment of rare and severe diseases. Established in 1994, the company serves as a key link between international pharmaceutical manufacturers and the Russian healthcare system, particularly within the framework of state-funded procurement programs. ORFE's portfolio includes innovative therapies for oncology, hematology, and orphan conditions, supported by a robust cold-chain logistics infrastructure. The company is recognized for its expertise in regulatory compliance and market access for specialized medicines in the Russian Federation. It plays a significant role in the 14 High-Cost Nosologies program, ensuring that patients with chronic disabling conditions receive necessary treatments. By partnering with global biotech leaders, ORFE facilitates the introduction of advanced medical technologies to the Russian market.